Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy
Circulation Research · 2024
DOI: 10.1161/circresaha.124.324588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, 2024. Verfasst von Nora Josefine Paulke und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Pneumology (N.J.P., C.F., J.B.W., G.C.R., M.M., N.Z., Y.Z., J.W., L.L., A.A.G., D.K.-D., E.W., T.K., K.T., G.H., S.E.L.,…. Hauptthemen laut MEDLINE: Dysferlin, Mice, Knockout, Myocytes, Cardiac, Cardiomegaly. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cardiac hypertrophy compensates for increased biomechanical stress of the heart induced by prevalent cardiovascular pathologies but can result in heart failure if left untreated. Here, we hypothesized that the membrane fusion and repair protein dysferlin is critical for the integrity of the transverse-axial tubule (TAT) network inside cardiomyocytes and contributes to the proliferation of TAT endomembranes during pressure overload–induced cardiac hypertrophy. METHODS: Stimulated emission depletion and electron microscopy were used to localize dysferlin in mouse and human cardiomyocytes. Data-independent acquisition mass spectrometry revealed the cardiac dysferlin interactome and proteomic changes of the heart in dysferlin-knockout mice. After transverse aortic constriction, we compared the hypertrophic response of wild-type versus dysferlin-knockout hearts and studied TAT network remodeling mechanisms inside cardiomyocytes by live-cell membrane imaging. RESULTS: We localized dysferlin in a vesicular compartment in nanometric proximity to contact sites of the TAT network with the sarcoplasmic reticulum, a.k.a. junctional complexes for Ca 2+ -induced Ca 2+ release. Interactome analyses demonstrated a novel protein interaction of dysferlin with the membrane-tethering sarcoplasmic reticulum protein juncophilin-2, a putative interactor of L-type Ca 2+ channels and ryanodine receptor Ca 2+ release channels in junctional complexes. Although the dysferlin-knockout caused a mild progressive phenotype of dilated cardiomyopathy, global proteome analysis revealed changes preceding systolic failure. Following transverse aortic constriction, dysferlin protein expression was significantly increased in hypertrophied wild-type myocardium, while dysferlin-knockout animals presented markedly reduced left-ventricular hypertrophy. Live-cell membrane imaging showed a profound reorganization of the TAT network in wild-type left-ventricular myocytes after transverse aortic constriction with robust proliferation of axial tubules, which critically depended on the increased expression of dysferlin within newly emerging tubule components. CONCLUSIONS: Dysferlin represents a new molecular target in cardiac disease that protects the integrity of tubule-sarcoplasmic reticulum junctional complexes for regulated excitation-contraction coupling and controls TAT network reorganization and tubular membrane proliferation in cardiomyocyte hypertrophy induced by pressure overload.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology and Pneumology (N.J.P., C.F., J.B.W., G.C.R., M.M., N.Z., Y.Z., J.W., L.L., A.A.G., D.K.-D., E.W., T.K., K.T., G.H., S.E.L., S.B.), University Medical Center Göttingen, Germany.
- Cellular Biophysics and Translational Cardiology Section, Heart Research Center (N.J.P., C.F., J.B.W., G.C.R., M.M., N.Z., Y.Z., J.W., L.L., A.A.G., D.K.-D., E.W., T.K., S.E.L., S.B.), University Medical Center Göttinge…
- Biochemistry of Membrane Dynamics Group, Institute for Auditory Neuroscience and InnerEarLab (C.C., J.P.), University Medical Center Göttingen, Germany.
- Department of Neurogenetics, Electron Microscopy, City Campus (W.M.).
- Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Germany (W.M., C.W., H.U., K.T., G.H., T.M., J.P., C.L., S.E.L., S.B.).
- Now with Institute of Transfusion Medicine, University Hospital Schleswig-Holstein; Kiel, Germany (D.K.-D).
ORCID-Profile: Nora Josefine Paulke, Justus B Wegener, Constantin Cretu, Mufassra Mushtaq, Wiebke Möbius, Yannik Zühlke, Eva Wagner, Tobias Kohl, Carolin Wichmann, Olaf Jahn, Karl Toischer, Tobias Moser, Christof Lenz, Eva A Rog-Zielinska, Stephan E Lehnart, Sören Brandenburg
Zitieren
APA
Paulke, N. J., Fleischhacker, C., Wegener, J. B., Riedemann, G. C., Cretu, C., Mushtaq, M., Zaremba, N., Möbius, W., Zühlke, Y., Wedemeyer, J., Liebmann, L., Gorshkova, A. A., Kownatzki-Danger, D., Wagner, E., Kohl, T., Wichmann, C., Jahn, O., Urlaub, H., Toischer, K., …, & Brandenburg, S. (2024). Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy. Circulation Research. https://doi.org/10.1161/circresaha.124.324588
Vancouver
Paulke NJ, Fleischhacker C, Wegener JB, Riedemann GC, Cretu C, Mushtaq M, et al. Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy. Circulation Research. 2024. doi:10.1161/circresaha.124.324588
BibTeX
@article{Paulke2024,
author = {Paulke, Nora Josefine and Fleischhacker, Carolin and Wegener, Justus B and Riedemann, Gabriel C and Cretu, Constantin and Mushtaq, Mufassra and Zaremba, Nina and Möbius, Wiebke and Zühlke, Yannik and Wedemeyer, Jasper and Liebmann, Lorenz and Gorshkova, Anastasiia A and Kownatzki-Danger, Daniel and Wagner, Eva and Kohl, Tobias and Wichmann, Carolin and Jahn, Olaf and Urlaub, Henning and Toischer, Karl and Hasenfuß, Gerd and Moser, Tobias and Preobraschenski, Julia and Lenz, Christof and Rog-Zielinska, Eva A and Lehnart, Stephan E and Brandenburg, Sören},
title = {Dysferlin Enables Tubular Membrane Proliferation in Cardiac Hypertrophy},
journal = {Circulation Research},
year = {2024},
doi = {10.1161/circresaha.124.324588}
}
EUVIMED